Topical chemoprevention of skin cancer in mice, using combined inhibitors of 5-lipoxygenase and cyclo-oxygenase-2

作者: L Fegn , Z Wang

DOI: 10.1017/S0022215109004617

关键词:

摘要: Objective: Skin cancer is the most common cancer, and often occurs in head neck region. This study aimed to investigate whether a combination of inhibitors cyclo-oxygenase-2 5-lipoxygenase, applied via microemulsion delivery system, would be effective topically inhibiting skin carcinogenesis. Study design: Randomised animal study. Methods: Twenty-four nude mice were intradermally inoculated with carcinoma cells then divided into three groups (eight animals each): group one received no treatment; two celecoxib alone; zileuton celecoxib. Tumour incidence growth measured for 14 days. Results: Both treatments significantly delayed onset development tumours. However, combined treatment had best response ( p Conclusion: The results clearly showed that topical either alone or plus inhibited carcinogenesis, both agents results.

参考文章(20)
Satya Priya Moulik, Saroj Kumar Ghosal, Natesan Subramanian, Topical delivery of celecoxib using microemulsion. Acta Poloniae Pharmaceutica. ,vol. 61, pp. 335- 341 ,(2004)
T Takano, H R Brady, H Holthöfer, M J Hébert, Sequential morphologic events during apoptosis of human neutrophils. Modulation by lipoxygenase-derived eicosanoids. Journal of Immunology. ,vol. 157, pp. 3105- 3115 ,(1996)
A. Jemal, R. Siegel, E. Ward, T. Murray, J. Xu, M. J. Thun, Cancer statistics, 2007. CA: A Cancer Journal for Clinicians. ,vol. 57, pp. 43- 66 ,(2007) , 10.3322/CANJCLIN.57.1.43
Natesan Subramanian, Saroj Kumar Ghosal, Asis Acharya, Satya Priya Moulik, Formulation and physicochemical characterization of microemulsion system using isopropyl myristate, medium-chain glyceride, polysorbate 80 and water. Chemical & Pharmaceutical Bulletin. ,vol. 53, pp. 1530- 1535 ,(2005) , 10.1248/CPB.53.1530
Traci A. Wilgus, Alane T. Koki, Ben S. Zweifel, Donna F. Kusewitt, Patricia A. Rubal, Tatiana M. Oberyszyn, Inhibition of cutaneous ultraviolet light B–mediated inflammation and tumor formation with topical celecoxib treatment Molecular Carcinogenesis. ,vol. 38, pp. 49- 58 ,(2003) , 10.1002/MC.10141
Traci A. Wilgus, Thomas S. Breza, Kathleen L. Tober, Tatiana M. Oberyszyn, Treatment with 5-Fluorouracil and Celecoxib Displays Synergistic Regression of Ultraviolet Light B-Induced Skin Tumors Journal of Investigative Dermatology. ,vol. 122, pp. 1488- 1494 ,(2004) , 10.1111/J.0022-202X.2004.22606.X
Nicholas G. Read, Paul J. Astbury, Gareth O. Evans, David A. Goodwin, Ann Rowlands, Nephrotic syndrome associated with N-hydroxyureas, inhibitors of 5-lipoxygenase Archives of Toxicology. ,vol. 69, pp. 480- 490 ,(1995) , 10.1007/S002040050202
A. S. Tsao, E. S. Kim, W. K. Hong, Chemoprevention of Cancer CA: A Cancer Journal for Clinicians. ,vol. 54, pp. 150- 180 ,(2004) , 10.3322/CANJCLIN.54.3.150
G. Ara, B.A. Teicher, Cyclooxygenase and lipoxygenase inhibitors in cancer therapy. Prostaglandins Leukotrienes and Essential Fatty Acids. ,vol. 54, pp. 3- 16 ,(1996) , 10.1016/S0952-3278(96)90075-7
YN Ye, WKK Wu, VY Shin, IC Bruce, BCY Wong, CH Cho, Dual inhibition of 5-LOX and COX-2 suppresses colon cancer formation promoted by cigarette smoke. Carcinogenesis. ,vol. 26, pp. 827- 834 ,(2005) , 10.1093/CARCIN/BGI012